http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022001201-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3cfc3ddba0550c7f2066a4ee86ab4283
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-30096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00761
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-10056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-30242
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-30088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-10101
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-0218
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-10021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-062
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4848
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-0047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00452
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4842
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-3205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H30-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T7-0012
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T7-0016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-062
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-30
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-3205
filingDate 2021-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a050ce9b3b1a20539b48d98fcc17d7d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5800998a9149c4241d54e5d26f2619b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f5d137be510f7dd1782c9029aca4083
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7c907aeec6d0a941519d4b83a79b0f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0dfa708662d04da8530cd7ba09c7131c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27bf2be3d9047efb56520128d681d3ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d50562ed98425606ee6ff94116dc175
publicationDate 2022-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2022001201-A1
titleOfInvention Method for Treating Cancerous and Pre-Cancerous Skin
abstract The present disclosure provides a method for treating clinical or pre-clinical skin damage in a skin field of a subject, wherein the skin field has been allocated a skin cancerization field index (SCFI) score of at least 1 as determined by a process comprising the steps of: (i) assessing the number of keratoses in the skin field; (ii) assessing the thickness of the thickest keratosis in the skin field; and (iii) assessing the proportion of the field affected by clinical or subclinical skin damage. Based on the assessments made in (i), (ii) and (iii) the subject is optionally treated by at least one of (a) freezing one or more lesions, (b) shaving, curetting or surgically removing one or more lesions, (c) applying a topical treatment for actinic keratosis, basal cell carcinoma or squamous cell carcinoma, and (d) radiation therapy.
priorityDate 2020-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395154
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID442042
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395923
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57469
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414059
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71398
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226655435

Total number of triples: 67.